Case Study - Pipeline Assessment Consulting Services

Objective :

Assessment of pipeline activities around client’s area of interest to support strategic decisions

Problem Statement:

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.

Our Methodology:

Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products
Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena
Company Assessment via Funding/Collaboration/Partnership Analysis
Analyst Comments on R&D developments

Results:

Detailed pipeline profiles of T-Cell Receptor (TCR) products
Additional comments on Inactive (Discontinued and Dormant) products.
Therapeutic assessment of active pipeline products
Detailed profiles of Companies with key coverage of collaboration/partnering activities

Related case Studies

Product Assessment Asset Prioritization Competitive Benchmarking Competitive Intelligence Due Diligence R&D Analysis Partner Identification

Sample Visuals

Get Visuals

Related Insights

Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

View Case

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case

Competitive Benchmarking

A large pharmaceutical client based in Europe involved DelveInsight to identify patient advocacy strategies of companies operating in the Pharma sector of the European Union, to benchmark their efforts against their competitors. [...]

View Case